This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Hydromorphone Nasal Spray
Ikano Therapeutics, Inc.
Drug Names(s): Hydromorphone Nasal Spray
Description: Hydromorphone Nasal Spray is a formulation of the opoiod hydromorphone, designed for more rapid onset of action than the oral drug. It is given by a unit dose, bi-dose and controlled multiple unit dose delivery devices, which have built-in control mechanisms to limit abuse potential.
Hydromorphone Nasal Spray News
Pink Sheet FDA’s ANDA Approvals
Pink Sheet May ANDA Approvals
Additional information available to subscribers only: